2026

Cellular interactions and immunometabolic mechanisms in heart failure with preserved ejection fraction: from molecular mechanisms to clinical evidence.
Peikert, Alexander, Vacca, Antonio, Norata, Giuseppe D., Schiattarella, Gabriele G. and Osto, Elena
Circulation Heart Failure : e012674. 2 February 2026 (In Press)

What exactly is cardiometabolic HFpEF: a phenotype or an endotype?
Packer, Milton, Schiattarella, Gabriele G. and Borlaug, Barry
Circulation Heart Failure : e014031. 23 January 2026 (In Press)

2024

Protein biomarkers of adverse clinical features and events in sarcomeric hypertrophic cardiomyopathy.
Tahir, U.A., Kolm, P., Kwong, R.Y., Desai, M.Y., Dolman, S.F., Deng, S., Appelbaum, E., Desvigne-Nickens, P., DiMarco, J.P., Tiwari, G., Friedrich, M.G., Zelaya-Portillo, J.H., Jerosch-Herold, M., Kim, D.Y., Maron, M.S., Piechnik, S.K., Schulz-Menger, J., Watkins, H., Weintraub, W.S., Neubauer, S., Kramer, C.M., Jarolim, P., Gerszten, R.E. and Ho, C.Y.
Circulation Heart Failure 17 (12): e011707. December 2024

2012

Myocardial systolic and diastolic performance derived by 2-dimensional speckle tracking echocardiography in heart failure with normal left ventricular ejection fraction.
Morris, D.A., Boldt, L.H., Eichstaedt, H., Oezcelik, C. and Haverkamp, W.
Circulation Heart Failure 5 (5): 610-620. September 2012